Your browser doesn't support javascript.
loading
Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma.
Hua, Shan; Xie, Zhiwen; Zhang, Yongqing; Wu, Lei; Shi, Fei; Wang, Xingjie; Xia, Shujie; Dong, Shengli; Jiang, Juntao.
Afiliação
  • Hua S; Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Xie Z; Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhang Y; Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wu L; Department of Urology, Shanghai General Hospital of Nanjing Medical University, Shanghai, China.
  • Shi F; Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang X; Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Xia S; Department of Urology, Shanghai General Hospital of Nanjing Medical University, Shanghai, China.
  • Dong S; Nursing Department, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Jiang J; Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Front Immunol ; 13: 869297, 2022.
Article em En | MEDLINE | ID: mdl-35936012

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
...